CTRI/2022/12/047982尚未招募未知
Efficacy and safety of Tab bilastine 20 mg vs Tab levocetirizine 10 mg in chronic urticaria patients attending tertiary care hospital Bhavnagar, Gujarat: A randomized control trial
Dr Jaydev Singh0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients of acute & chronic urticaria aged between 18-75 years.
- •Patients who are willing to give written informed consent
- •Patients with minimum UAS of 5 or greater than it
排除标准
- •Patients with : Urticarial vasculitis
- •Senile prutitus
- •Drug induced urticaria
- •Herediatary angioedema will be excluded
- •Patient taken antihistaminic in last 4 weeks
- •Patient taken corticosteroid in last 4 weeks
- •Patient having known hypersensitivity to the drug
- •Patients on immunosuppressive therapy ( cyclosporine, methotrexate, azathioprine)
- •Pregnant and lactating females
研究者
相似试验
尚未招募
4 期
Safety and Effectiveness of Bilastine and Fexofenadine in Perennial Allergic Rhinitis patientsCTRI/2024/07/071414Teerthanker Mahaveer Medical College and Research Centre Moradabad
已完成
3 期
Efficacy Study for the Symptomatic Treatment of Seasonal Allergic RhinitisSeasonal Allergic RhinitisNCT00504933Faes Farma, S.A.683
已完成
不适用
Bioequivalence study of bilastine 20 mg under fasting condition in Healthy Thai volunteerBioequivalence study of bilastine 20 mgBioequivalence study of bilastine 20 mg under fasting condition in Healthy Thai volunteerTCTR20190824002All Research Co., Ltd.28
已完成
3 期
Investigate the Safety/Tolerability and Efficacy of Bilastine 20mg in Korean Patients With Seasonal Allergic RhinitisSeasonal Allergic RhinitisNCT01400828Yuhan Corporation239
已完成
3 期
Efficacy Study for the Symptomatic Treatment of Chronic Idiopathic UrticariaUrticariaNCT00421109Faes Farma, S.A.522